Vagal nerve stimulation prevents reperfusion injury through inhibition of opening of mitochondrial permeability transition pore independent of the bradycardiac effect

Journal of Thoracic and Cardiovascular Surgery

Volumn 137, Issue 1, 2009, Pages 223-231

  Katare, Rajesh G ^a   Ando, Motonori ^a,b   Kakinuma, Yoshihiko ^a   Arikawa, Mikihiko ^a   Handa, Takemi ^a   Yamasaki, Fumiyasu ^a   Sato, Takayuki ^a  

^a KOCHI MEDICAL SCHOOL   (Japan)

^b OKAYAMA UNIVERSITY   (Japan)

Author keywords

[No Author keywords available]

Indexed keywords

ACETYLCHOLINE; ATRACTYLOSIDE; MITOCHONDRIAL PERMEABILITY TRANSITION PORE;

ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; BRADYCARDIA; HEART LEFT VENTRICLE ENDDIASTOLIC PRESSURE; HEART PERFUSION; HEART RATE; MALE; NONHUMAN; OUTCOME ASSESSMENT; PRIORITY JOURNAL; RAT; REPERFUSION; REPERFUSION INJURY; VAGUS NERVE STIMULATION;

ANIMALS; BRADYCARDIA; ELECTRIC STIMULATION THERAPY; MALE; MITOCHONDRIAL MEMBRANE TRANSPORT PROTEINS; RATS; RATS, WISTAR; REPERFUSION INJURY; VAGUS NERVE;

EID: 58249144126     PISSN: 00225223     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.jtcvs.2008.08.020     Document Type: Article

References (30)

1. Ishii H., Ichimiya S., Kanashiro M., Amano T., Imai K., Murohara T., et al. Impact of a single intravenous administration of nicorandil before reperfusion in patients with ST-segment-elevation myocardial infarction. Circulation 112 (2005) 1284-1288
2. Wu Z.K., Laurikka J., Saraste A., Kyto V., Pehkonen E.J., Savunen T., et al. Cardiomyocyte apoptosis and ischemic preconditioning in open heart operations. Ann Thorac Surg 76 (2003) 528-534
3. Shanmuganathan S., Hausenloy D.J., Duchen M.R., and Yellon D.M. Mitochondrial permeability transition pore as a target for cardioprotection in the human heart. Am J Physiol Heart Circ Physiol 289 (2005) H237-H242
4. Ando M., Katare R.G., Kakinuma Y., Zhang D., Yamasaki F., Muramoto K., et al. Efferent vagal nerve stimulation protects heart against ischemia-induced arrhythmias by preserving connexin43 protein. Circulation 112 (2005) 164-170
5. Kakinuma Y., Ando M., Kuwabara M., Katare R.G., Okudela K., Kobayashi M., et al. Acetylcholine from vagal stimulation protects cardiomyocytes against ischemia and hypoxia involving additive non-hypoxic induction of HIF-1alpha. FEBS Lett 579 (2005) 2111-2118
6. Murry C.E., Jennings R.B., and Reimer K.A. Preconditioning with ischemia: a delay of lethal cell injury in ischemic myocardium. Circulation 74 (1986) 1124-1136
7. Yellon D.M., and Downey J.M. Preconditioning the myocardium: from cellular physiology to clinical cardiology. Physiol Rev 83 (2003) 1113-1151
8. Krieg T., Qin Q., Philipp S., Alexeyev M.F., Cohen M.V., and Downey J.M. Acetylcholine and bradykinin trigger preconditioning in the heart through a pathway that includes Akt and NOS. Am J Physiol Heart Circ Physiol 287 (2004) H2606-H2611
9. Zhao Z.Q., Corvera J.S., Halkos M.E., Kerendi F., Wang N.P., Guyton R.A., et al. Inhibition of myocardial injury by ischemic postconditioning during reperfusion: comparison with ischemic preconditioning. Am J Physiol Heart Circ Physiol 285 (2003) H579-H588
10. Hausenloy D.J., and Yellon D.M. New directions for protecting the heart against ischaemia-reperfusion injury: targeting the Reperfusion Injury Salvage Kinase (RISK)-pathway. Cardiovasc Res 61 (2004) 448-460
11. Kawada T., Yamazaki T., Akiyama T., Li M., Ariumi H., Mori H., et al. Vagal stimulation suppresses ischemia-induced myocardial interstitial norepinephrine release. Life Sci 78 (2006) 882-887
12. Green D.R., and Kroemer G. The pathophysiology of mitochondrial cell death. Science 305 (2004) 626-629
13. Miyano H., Nakayama Y., Shishido T., Inagaki M., Kawada T., Sato T., et al. Dynamic sympathetic regulation of left ventricular contractility studied in the isolated canine heart. Am J Physiol Heart Circ Physiol 275 (1998) H400-H408
14. Rajesh K.G., Sasaguri S., Ryoko S., and Maeda H. Mitochondrial permeability transition-pore inhibition enhances functional recovery after long-time hypothermic heart preservation. Transplantation 76 (2003) 1314-1320
15. Yamamura T., Otani H., Nakao Y., Hattori R., Osako M., and Imamura H. IGF-I differentially regulates Bcl-xL and Bax and confers myocardial protection in the rat heart. Am J Physiol Heart Circ Physiol 280 (2001) H1191-H1200
16. Steel R.G.D. A rank sum test for comparing all pairs of treatments. Technometrics 2 (1960) 197-207
17. Dwass M. Some k-sample rank-order tests. In: Olkin I. (Ed). Contributions to Probability and Statistics (1960), Stanford University Press, Stanford 198-202
18. Kloner R.A., and Rezkalla S.H. Preconditioning, postconditioning and their application to clinical cardiology. Cardiovasc Res 70 (2006) 297-307
19. Tomai F., Crea F., Chiariello L., and Gioffrè P.A. Ischemic preconditioning in humans: models, mediators, and clinical relevance. Circulation 100 (1999) 559-563
20. Laskey W.K. Brief, repetitive balloon occlusions enhance reperfusion during percutaneous coronary intervention for acute myocardial infarction. Catheter Cardiovasc Interv 65 (2005) 361-367
21. Staat P., Rioufol G., Piot C., Cottin Y., Cung T.T., L'Huillier I., et al. Postconditioning the human heart. Circulation 112 (2005) 2143-2148
22. Philipp S., Yang X.M., Cui L., Davis A.M., Downey J.M., and Cohen M.V. Postconditioning protects rabbit hearts through a protein kinase C-adenosine A2b receptor cascade. Cardiovasc Res 70 (2006) 308-314
23. O'Brien P., Drage D., Saeian K., Brooks H.L., and Warltier D.C. Regional redistribution of myocardial perfusion by UL-FS 49, a selective bradycardic agent. Am Heart J 123 (1992) 566-574
24. Halestrap A.P., Kerr P.M., Javadov S., and Woodfield K.Y. Elucidating the Molecular mechanism of the permeability transition pore and its role in reperfusion injury. Biochim Biophys Acta 1366 (1998) 79-94
25. Murphy E. Primary and secondary signaling pathways in early preconditioning that converge on the mitochondria to produce cardioprotection. Circ Res 94 (2004) 7-16
26. Ronson R.S., Puskas J.D., Thourani V.H., Velez D.A., Bufkin B.L., Glass J., et al. Controlled intermittent asystole cardiac therapy induced by pharmacologically potentiated vagus nerve stimulation in normal and hibernating myocardium. Ann Thorac Surg 75 (2003) 1929-1936
27. Bufkin B.L., Puskas J.D., Vinten-Johansen J., Shearer S.T., and Guyton R.A. Controlled intermittent asystole: pharmacologic potentiation of vagal-induced asystole. Ann Thorac Surg 66 (1998) 1185-1190
28. Gruppo Italiano per lo Studio della Streptochinasi nell'Infarto Miocardico (GISSI). Effectiveness of intravenous thrombolytic treatment in acute myocardial infarction. Lancet 1 (1986) 397-402
29. The GUSTO Investigators. An international randomized trial comparing four thrombolytic strategies for acute myocardial infarction. N Engl J Med 329 (1993) 673-682
30. Schauerte P., Mischke K., Plisiene J., Waldmann M., Zarse M., Stellbrink C., et al. Catheter stimulation of cardiac parasympathetic nerves in humans: a novel approach to the cardiac autonomic nervous system. Circulation 104 (2001) 2430-2435